---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282963081.md"
description: "Hetero Pharmaceuticals plans to achieve annual sales of 1.5 million Semaglutide injection pens globally"
datetime: "2026-04-16T08:22:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282963081.md)
  - [en](https://longbridge.com/en/news/282963081.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282963081.md)
---

# 

Hetero Pharmaceuticals plans to achieve annual sales of 1.5 million Semaglutide injection pens globally

### Related Stocks

- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)

## Related News & Research

- [Novo Nordisk's stock rallies after drugmaker reveals deal with OpenAI](https://longbridge.com/en/news/282698267.md)
- [Health Rounds: Novo Nordisk weight-loss drug shows liver benefits in mouse study](https://longbridge.com/en/news/282732630.md)
- [Novo Nordisk’s Thalassemia Push Adds Rare Blood Upside To Valuation](https://longbridge.com/en/news/282666156.md)
- [10:44 ETApotex Receives First U.S. FDA Tentative Approval for a Generic Version of Ozempic® (Semaglutide Injection) in Partnership with Orbicular](https://longbridge.com/en/news/282362382.md)
- [Arcutis Biotherapeutics Targets ZORYVE Expansion, Raises 2026 Outlook and Turns Cash-Flow Positive](https://longbridge.com/en/news/282775123.md)